investors insulet.com

Investor Relations Insulet Corporation

The Investor Relations website contains information about Insulet Corporations business for stockholders, potential investors, and financial analysts.
traffic

OVERVIEW

This web site investors.insulet.com presently has a traffic classification of zero (the lower the better). We have sifted seventeen pages inside the web site investors.insulet.com and found zero websites referencing investors.insulet.com. I acquired two mass communication accounts linked to investors.insulet.com.
Pages Analyzed
17
Social Links
2

INVESTORS.INSULET.COM RANKINGS

This web site investors.insulet.com is seeing fluctuating quantities of traffic within the past the year.
Traffic for investors.insulet.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investors.insulet.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investors.insulet.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

WHAT DOES INVESTORS.INSULET.COM LOOK LIKE?

Desktop Screenshot of investors.insulet.com Mobile Screenshot of investors.insulet.com Tablet Screenshot of investors.insulet.com

INVESTORS.INSULET.COM HOST

Our web crawlers revealed that the main root page on investors.insulet.com took one hundred and seventy milliseconds to load. We could not observe a SSL certificate, so in conclusion we consider investors.insulet.com not secure.
Load time
0.17 seconds
SSL
NOT SECURE
Internet Address
23.55.218.214

FAVORITE ICON

SERVER OPERATING SYSTEM AND ENCODING

I found that investors.insulet.com is implementing the nginx os.

TITLE

Investor Relations Insulet Corporation

DESCRIPTION

The Investor Relations website contains information about Insulet Corporations business for stockholders, potential investors, and financial analysts.

CONTENT

This web site states the following, "Investor Relations and Corporate Communications." Our analyzers noticed that the web site stated " Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections MDI; these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability." The Website also said " And improved quality of life. 1 Diabetes Control and Complications Trial Researc."

VIEW SIMILAR BUSINESSES

IBKR Investor Relations Information Services

IBKR aims to provide an exceptionally inexpensive and versatile platform for our clients to manage their finances. It is vitally important to us that our clients be better equipped, pay lower prices, and have other advantages so as to generate higher returns than the customers of other brokers. You may be considering investing in IBKR. We would like to ask you not to buy our shares unless you become an active user of our platform prior to doing so.

interpublic investors summary IPG

Through our 48,400 employees in all major world markets, our companies specialize in consumer advertising, digital marketing, communications planning and media buying, public relations and specialized communications disciplines. IPG Presents 2015 Inclusion Awards.

Interxion Investor Relations Investor Relations Homepage

We support over 1,200 customers through 29 data centres across 11 countries. Read about the history of Interxion and our vision for the future. Learn about the people behind our success. Find an office near you. What is a carrier-neutral data centre. Why outsource your data centre? Befor.

Intrepid Potash Investor Relations Investor Relations

Click here to see our history. Intrepid Potash Announces Second Quarter and First Half 2015 Results. Intrepid Potash Announces Date for Second Quarter Earnings Release. Intrepid Potash to Present at BMO Farm to Market Conference.

iRobot Investors

IRobot designs and builds robots that make a difference. IRobot was founded in 1990 by Massachusetts Institute of Technology roboticists with the vision of making practical robots a reality. iRobot stock trades on the NASDAQ stock market under the ticker symbol IRBT.